跳至主要内容
临床试验/ISRCTN58371625
ISRCTN58371625已完成不适用

64CuCl2 PET/CT in presurgical evaluation of prostate cancer in patients with high risk of extracapsular disease: an observational study

Magna Graecia University of Catanzaro (Italy)0 个研究点目标入组 20 人开始时间: 2014年1月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Male

入选标准

  • 1. Age > 18 years
  • 2. High-risk prostate cancer patients defined planned for surgical treatment (radical prostatectomy with lymphadenectomy)
  • 3. Prostate-specific antigen (PSA) > 20 ng/ml
  • 4. Biopsy gleason score 8-10
  • 5. Stage = cT3a
  • 6. Negative bone scintigraphy and magnetic resonance imaging (MRI) of the pelvis negative for metastatic disease

排除标准

  • 1. Age < 18 years
  • 2. Evidence of metastatic disease
  • 3. Other tumours diagnosed within the past 5 years, except basal cell or squamous cell skin carcinoma, if properly treated
  • 4. Other medical or psychological diseases that could interfere with the participation in the study and follow-up controls
  • 5. Refusal to participate in the study and anonymous publication of data
  • 6. Participation in other clinical trials, including the follow-up period

研究者

发起方
Magna Graecia University of Catanzaro (Italy)

相似试验